Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
Gang XiaoLifeng LiGuilong TanzhuZhiyuan LiuXuan GaoXin WanDesheng XiaoLiu ChenXuefeng XiaRongrong ZhouPublished in: Journal for immunotherapy of cancer (2023)
This study found that LUAD-derived BMs exhibited an immunosuppressive TIME and revealed that EGFR-positive and ALK-positive BMs exhibited different immunosuppressive characteristics. Meanwhile, EGFR-negative BMs showed a potential benefit to immunotherapy. These findings boost molecular and clinical understanding of LUAD BMs.